Wexford Capital LP Astrazeneca PLC Transaction History

Wexford Capital LP

$340 Million
Q1 2025

A detailed history of Wexford Capital LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Wexford Capital LP holds 46,352 shares of AZN stock, worth $3.27 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

46,352

Previous 3,605 1185.77%

Holding current value

$3.27 Million

Previous $236,000 1343.22%

% of portfolio

1.0%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $2.79 Million - $3.33 Million	42,747 Added 1185.77%	46,352 $3.41 Million
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $602,549 - $688,605	-7,859 Reduced 68.55%	3,605 $280,000
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $4.3 Million - $5.2 Million	-64,326 Reduced 84.87%	11,464 $894,000
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $3.03 Million - $3.45 Million	-49,611 Reduced 39.56%	75,790 $5.13 Million
Q4 2023 Feb 15, 2024	BUY	$61.89 - $69.28 $4.24 Million - $4.75 Million	68,504 Added 120.4%	125,401 $8.45 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1.41 Million - $1.52 Million	-20,116 Reduced 26.12%	56,897 $4.07 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $4.64 Million - $5.26 Million	73,408 Added 2036.28%	77,013 $5.35 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $195,427 - $253,936	3,605 New	3,605 $244,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $2,841 - $3,423	51 Added 1.45%	3,578 $237,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $1,458 - $1,723	27 Added 0.77%	3,527 $205,000
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $169,470 - $210,630	3,500 New	3,500 $210,000
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $6.41 Million - $7.4 Million	-136,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $4.99 Million - $5.97 Million	102,819 Added 309.87%	136,000 $6.8 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $2.4 Million - $2.76 Million	-45,151 Reduced 57.64%	33,181 $1.82 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $3.38 Million - $4.33 Million	78,332 New	78,332 $4.14 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $7.01 Million - $8.5 Million	-197,573 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $7.28 Million - $8.2 Million	197,573 New	197,573 $7.5 Million

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Wexford Capital LP with notifications on news.

Account

Wexford Capital LP Astrazeneca PLC Transaction History